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Abstract  
In Nigeria, high prevalence of methicillin resistant Staphylococcus aureus (MRSA) in clinical samples and 
healthy individuals is increasingly being reported. However, very little is known regarding coagulase negative 
Staphylococci (CoNS) strains isolated from healthy individuals, especially, given their increasing recognition as 
agents of clinically significant infections and as reservoirs of antimicrobial resistance determinants. Therefore, 
this study was undertaken, to establish the prevalence of MRSA, and to characterize the antimicrobial 
susceptibility of CoNS strains from apparently healthy University student volunteers in Ota, Ogun State, Nigeria. 
A better characterization of CoNS strains in their commensal lifestyle could give us new insights on their 
pathogenic potential. A total of 100 (nose and neck swabs) samples were collected from healthy students and 
screened using standard microbiological techniques. Staphylococcus species isolated on the basis of growth on 
mannitol salt agar were further characterized based on biochemical tests and novobiocin resistance. 
Commercially prepared antibiotics discs were used to test the susceptibility of the Staphylococcus isolates 
obtained. Data generated were analyzed descriptively and expressed in percentages. A total of 39 Staphylococcus 
species were identified as S. aureus (17), S. saprophyticus (8), S. epidermidis (7), S. hemolyticus (5) and S. 
hominis (2). The S. aureus strains were highly resistant (>94%) to methicillin (oxacillin / cloxacillin) and several 
non-β-lactams including clindamycin (100%), co-trimoxazole (82.4%), and vancomycin (82.4%). The incidence 
of methicillin resistance among CoNS was 77.3% with moderate resistance to co-trimoxazole (63.6%), 
clindamycin (40.9%), gentamicin (36.36%) and vancomycin (31.8%). This study has demonstrated high 
prevalence of MRSA and MRCoNS isolates from apparently healthy University student volunteers in Ota, 
Nigeria, and underlines the need for periodic surveillance studies of this type, reassessment of policies on 
antibiotics use within and outside the University environments, development and enforcement of measures to 
prevent the spread of MRSA and MRCoNS infections in the community.   
Keywords: Coagulase-Negative Staphylococcus species (CoNS), Community-associated methicillin resistant 
Staphylococcus aureus (CA-MRSA), Multi-drug resistance, Nigeria, Susceptibility 
 
1. Introduction 
The Staphylococcus, consisting of 45 species, is a genus of Gram-positive cocci in grape-like clusters that are 
non-motile and catalase positive with ability to grow in a variety of conditions—aerobically, and anaerobically, 
in the presence of a high concentration of salt and at temperatures ranging from 18°C to 40°C (Ryan and Ray, 
2004; Murray et al., 2009). Staphylococcus aureus has the ability to coagulate blood using the coagulase enzyme 
and on the basis of this can be distinguished from most other coagulase-negative staphylococcal species (CoNS) 
such as S. epidermidis, S. saprophyticus, S. haemolyticus, S. hominis and S. lugdunensis (Ieven et al., 1995). 
Staphylococci are ubiquitous. All persons have coagulase-negative staphylococci on their skin, and transient 
colonization of moist skin folds with S. aureus is common (Murray et al., 2009).  
S. aureus is widely considered a major factor of nosocomial infections ranging from minor skin 
infections, osteomyelitis and endocarditis, to more serious infections including fatal necrotizing pneumonia 
(Archer, 1998). Although these infections were historically treatable, beginning in the 1980s, methicillin-
resistant S. aureus (MRSA) strains have spread rapidly in susceptible hospitalized patients, dramatically 
changing the therapy available for preventing and treating staphylococcal infections (Enright et al., 2002). 
Although MRSA infections were relatively uncommon among healthy individuals in the community, a dramatic 
change was observed in 2003 when new strains of MRSA were reported to be responsible for outbreaks of 
community-acquired cutaneous infections and severe pneumonia (Marcinak and Frank, 2003). MRSA infections 
present a challenge to infection control and treatment strategies, resulting in increased morbidity, mortality, and 
length of hospitalization and health care costs (Macedo-Viñas et al., 2013; Kim et al., 2001; Kim et al., 2014). 
Although, CoNS were historically considered harmless with relatively low virulence (Kloos and 
Banerman, 1994; von Eiff et al., 2001), they are increasingly recognized as agents of clinically significant 
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infections of the bloodstream and other sites. Data from a previous United States National Nosocomial Infections 
Surveillance System report showed that CoNS were the most commonly reported pathogens (37.3% for CoNS 
versus 12.6% for S. aureus) isolated from bloodstream infections in intensive care unit patients (Richards et al., 
1999).  The CoNS have been implicated as the causative agents in urinary tract disease, pneumonia, 
endophthalmitis, (Younger et al., 1987), surgical wound infections, breast abscess (Moazzez, 2007), 
osteomyelitis, native valve endocarditis (Marculescu et al., 2006), periodontitis, chronic rhinosinusitis, and otitis 
media (Post et al., 2004). Of particular note, is the propensity of some CoNS to form a protective biofilm which 
interferes with phagocytosis and efficacy of antimicrobial peptides (Otto, 2008; Fredheim et al., 2009; Oliveira 
and Cerca, 2013). More importantly, CoNS often serve as reservoirs of antimicrobial resistance determinants; 
resistance to penicillin approaches 90 to 95 percent, while resistance to methicillin and semisynthetic penicillins 
has been observed in more than 80 percent of CoNS isolates (Diekema et al., 2001), they are also often resistant 
to multiple classes of antibiotics in addition to β-lactams. Patients at particular risk for CoNS infections include 
those with prosthetic devices, pacemakers, intravascular catheters, and immunocompromised status (Murray et 
al., 2009).   
In Africa, MRSA prevalence varies with different countries, high in some and low in others (Falagas et 
al., 2013). In Nigeria, the prevalence of hospital associated-MRSA in clinical samples also varies from one area 
to another; 43% in Jos (Taiwo et al., 2004), 34.7% in Ilorin (Ikeh, 2003), 30.4% in Ibadan (Adetayo et al., 2014), 
28.6% in Kano (Nwakwo, 2010) and 12.5% in Maiduguri (Okon et al., 2011). Reports of studies on prevalence 
of community-associated MRSA (CA-MRSA) are also emerging in Nigeria; 10.8% in apparently healthy school 
children in Okada, Edo State (Okwu et al., 2012), 41% in apparently healthy University students in Ekpoma, 
also of Edo State (Eke et al., 2012), 60.7% in otherwise healthy inhabitants of Uturu communities in Abia State 
(Ibe et al., 2013), 71.7% in healthy women volunteers in the Abuja Capital Territory (Onanuga et al., 2005).  
However, despite the increasing recognition of CoNS as agents of clinically significant infection and their 
resistance to multiple classes of antibiotics in addition to beta-lactams, very little is known in Nigeria regarding 
CoNS strains isolated from healthy individuals in the community. This study was undertaken, to establish the 
prevalence of MRSA, and to characterize the antimicrobial susceptibility of CoNS strains from the skin (neck) 
and nose of apparently healthy University student volunteers in Ota, Ogun State of Nigeria.  The antimicrobial 
susceptibility profile of the staphylococcal isolates may inform about possible sources of antimicrobial resistance 
in the community. The sensitivity of the isolates to selected antimicrobials may guide clinical treatment 
decisions. A surveillance study of this type in the community may highlight the need for reassessment of policies 
on antibiotics use within and outside the University environments, and development of measures to prevent the 
spread of MRSA and MRCoNS infections in the community.  
 
2. Materials and Methods  
Study area: This study was carried out in Ota, Ado/Ota Local Government Area of Ogun State, Nigeria. 
Subjects: A total of 100 apparently healthy students of Covenant University, Ota (50 males; 50 females) served 
as the study population. The participants were asked to complete a questionnaire regarding gender, 
hospitalization history, antibiotic use, and contact with medical staff in the preceding six months.  
Ethical Approval: All the participants in this study gave written informed consent following exchange of 
information about the study background and procedures with preservation of their autonomy, privacy, and 
confidentiality. The study was approved by the Research Ethics Committee of the Department of Biological 
Sciences, Covenant University, Ota, Ogun State of Nigeria. 
Study Duration: This study was carried out within a period of three months. 
Sample Collection and Media: A total of 100 swab samples (50 nose and 50 neck) were collected from 
apparently healthy male and female Covenant University student volunteers (male- 25 nose and 25 neck, female- 
25 nose and 25 neck). All samples were collected using swab stick soaked in sterile saline, labelled, packaged 
and transported immediately to the laboratory for microbiological studies. The media used for this study include 
the following: Nutrient broth (Oxoid), Nutrient agar (Biomark), Mannitol salt agar (Biomark), Blood agar 
(Biomark), and Mueller Hinton agar (Oxoid). All microbiological media were prepared following 
manufacturers’ instructions. 
Identification and characterization of bacterial isolates: The nose and neck swab specimens were inoculated on 
Mannitol salt agar (MSA). The culture plates were incubated at 350C for 48 hours under aerobic conditions 
following which they were examined, and the appearance, colour, size and morphology of the colonies were 
recorded. The Gram stain reaction was carried out on the bacterial isolates and they were further characterised to 
species level based on the results obtained from a series of biochemical tests including catalase production, 
coagulase activity, blood agar hemolysis and novobiocin (5µg) susceptibility assay (Ryan and Ray, 2004). The 
bacterial isolates were further sub-cultured on agar slants and incubated at 350C for 24 hours, following which 
they were stored at 40C. 
Determination of Antimicrobial Susceptibility Pattern: The bacterial isolates were tested for susceptibility to 13 
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different antimicrobial agents by the disc diffusion method on Mueller Hinton agar (Bauer et al., 1966). The 
antimicrobial agents tested were: augmentin, 30µg (AUG), amoxicillin, 25µg (AMX), erythromycin, 15µg 
(ERY), tetracycline, 30µg (TET), cloxacillin, 5µg (CXC), gentamicin, 10µg (GEN), co-trimoxazole, 25µg 
(COT), chloramphenicol, 25µg (CHL), oxacillin, 5µg (OX), novobiocin, 5µg (NV), clindamycin, 0.5µg (DA), 
vancomycin, 5µg (VA) and penicillin, 10µg (P). The antibiotics discs were placed on Mueller Hinton agar plates 
previously seeded with 0.5ml of inoculum (1.5 x 108 colony forming unit) of isolates. The plates were incubated 
at 350C for 24 hours and observed for zones of inhibition, determined by measurement using a ruler and recorded. 
Each isolate was tested in two independent occasions in triplicate. Zone size less than 12 mm was considered 
resistant and zone size greater or equal to 16 mm was considered sensitive. Multiple antibiotic resistance was 
defined as resistance to three or more classes of antimicrobial agents. 
Statistical Analysis: Data generated were analysed descriptively and expressed in percentages.  
 
3. Results 
Isolation and Identification of Staphylococcus species 
The student volunteers denied visiting the Covenant University Healthcare centre or any hospital in the six 
months prior to enlistment for this study. Similarly, they reported not taken any antibiotics medication during the 
prior six months nor did they have any skin abrasion or open wound prior to and during the sampling period. 
Following cultivation of sample swab streaks from the apparently healthy University students on MSA plates for 
48 hours, growth was seen on 39 out of 100 plates. The results showed that of the 50 nose swabs examined, 24 
samples yielded positive for Staphylococcus species and also, of 50 samples of neck swabs examined, 15 yielded 
positive for Staphylococcus species as seen in Table I. The number of S. aureus isolated from nose was 10 
(41.7%) and from neck was 7 (47%) as shown in Table I. Among the Staphylococcus species isolated, the 
prevalence of S. aureus was higher; the species distribution of the analysed strains was as follows: S. aureus- 17 
strains (43.6%), S. saprophyticus- 8 strains (20.5%), S. epidermidis- 7 strains (17.9%), S. hemolyticus- 5 strains 
(12.8%), and S. hominis- 2 strains (5%) as seen in Table I. 
TABLE I: Identification of Staphylococcus species isolated from healthy University students 
Source   Species    No. of Isolates  Frequency (%) 
Nose    S. aureus   10   41.7 
    S. epidermidis    6   25 
    S. saprophyticus    4   16.7 
    S. hemolyticus    3   12.5 
    S. hominis     1    4.2 
Neck   S. aureus     7   46.7 
    S. epidermidis     1    6.7 
    S. saprophyticus    4   26.7 
    S. hemolyticus    2   13.3 
    S. hominis     1    6.7 
 
Antimicrobial Susceptibility of Staphylococcus species  
The Staphylococcus species isolated from apparently healthy University students examined in this study 
demonstrated resistance to tested antibiotics (Table II a, b and c).   
S. aureus strains were highly resistant to oxacillin (100%), clindamycin (100%), amoxicillin (94.1%), cloxacillin 
(94.1%), co-trimoxazole (82.4%), penicillin (82.4%), vancomycin (82.4%), and augmentin (76.5%), and 
moderately resistant to erythromycin (58.8%), gentamicin (58.8%), chloramphenicol (58.8%) and tetracycline 
(47.1%).  
S. saprophyticus strains were highly resistant to oxacillin (87.5%), penicillin (87.5%), and clindamycin (75%), 
moderately resistant to co-trimoxazole (62.5%), vancomycin (62.5%), and cloxacillin (62.5%), while highly 
sensitive to gentamicin (12.5%), chloramphenicol (12.5%), and tetracycline (12.5%), and moderately sensitive to 
erythromycin (25%), augmentin (37.5%), and amoxicillin (37.5%).  
S. epidermidis strains were highly resistant to co-trimoxazole (85.7%), oxacillin (71.4). amoxicillin (71.4%), 
cloxacillin (71.4%), augmentin (71.4%), moderately resistant to gentamicin (57.1%) while sensitive to 
tetracycline (42.9%), penicillin (42.9%), erythromycin (28.6%), chloramphenicol (14.3%), clindamycin (14.3%) 
and very sensitive to novobiocin (0%), vancomycin (0%).  
S. hemolyticus strains were highly resistant to oxacillin (80%), coxacillin (80%), amoxicillin (80%), and 
augmentin (80%), moderately resistant to penicillin (60%), co-trimoxazole (60%), and gentamicin (60%) while 
sensitive to erythromycin (20%), tetracycline (20%), vancomycin (20%) and very sensitive to novobiocin (0%), 
chloramphenicol (0%).  
The S. hominis strains demonstrated high sensitivity to eight of the 13 antibiotics tested. 
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Table II a: The number/percentage (%) of Staphylococcus species resistant to selected antibiotics 
Species (No. of strains)  AUG  AMX  ERY  TET  
S. aureus (17)   13/76.5  16/94.1  10/58.8  8/47.1 
S. saprophyticus (8)  3/37.5  3/37.5  2/25  1/12.5 
S. epidermidis (7)  5/71.4  5/71.4  2/28.6  3/42.9 
S. hemolyticus (5)  4/80  4/80  1/20  1/20 
S. hominis (2)   0/0  1/50  0/0  0/0 
AUG- Augmentin, AMX- Amoxicillin, ERY- Erythromycin, and TET- Tetracyline 
 
Table II b: The number/percentage (%) of Staphylococcus species resistant to selected antibiotics 
Species (No. of strains)  CXC  GEN  COT  CHL   
S. aureus (17)   16/94.1  10/58.8  14/82.4  10/58.8 
S. saprophyticus (8)  5/62.5  1/12.5  5/62.5  1/12.5 
S. epidermidis (7)  5/71.4  4/57.1  6/85.7  1/14.3 
S. hemolyticus (5)  4/80  3/60  3/60  0/0 
S. hominis (2)   1/50  0/0  0/0  0/0 
CXC- Cloxacillin, GEN- Gentamycin, COT- Cotrimoxazole and CHL- Chloramphenicol 
 
Table II c: The number/percentage (%) of Staphylococcus species resistant to selected antibiotics 
Species (No of Strains) OX  NV  DA  VA  P 
S. aureus (17)  17/100  0/0  17/100  14/82.4  14/82.4 
S. saprophyticus (8) 7/87.5  8/100  6/75  5/62.5  7/87.5 
S. epidermidis(7)  5/71.4  0/0  1/14.3  0/0  3/42.9 
S. hemolyticus (5) 4/80  0/0  2/40  1/20  3/60 
S. hominis (2)  1/50  0/0  0/0  1/50  1/50 
OX- Oxacillin, NV- Novobiocin, DA- Clindamycin, VA- Vancomycin and P- Penicillin.  
Strains of Staphylococcus species isolated from healthy University student volunteers were highly sensitive to 
chloramphenicol (69.2% -sensitive strains), tetracycline (66.7% -sensitive strains), and erythromycin (61.5% -
sensitive strains) while oxacillin (87.2% -resistant strains), cloxacillin (79.5% -resistant strains), amoxicillin 
(74.4% -resistant strains), co-trimoxazole (71.8% - resistant strains), penicillin (69.2% -resistant strains), 
augmentin (64.1% -resistant strains) and vancomycin (51.3% -resistant strains) showed low anti-Staphylococcal 
activity (Fig. 1). 
 
Fig 1: The proportion of sensitive and resistant Staphylococcus species to the tested antibiotics.  
AUG- Augmentin, AMX- Amoxicillin, ERY- Erythromycin, TET- Tetracyline, CXC- Cloxacillin, 
GEN- Gentamycin, COT- Cotrimoxazole, CHL- Chloramphenicol, OX- Oxacillin, NV- Novobiocin, DA- 
Clindamycin, VA- Vancomycin, and P- Penicillin. 
The susceptibility profile for all CoNS strains isolated and characterized in this study demonstrated that 
they were also highly sensitive to chloramphenicol (80% -sensitive strains), erythromycin (68% -sensitive strains) 
and tetracycline (68% -sensitive strains) while oxacillin (77.2% -resistant strains), penicillin (63.64% -resistant 
strains), cloxacillin (68.2% -resistant strains), co-trimoxazole (63.6% -resistant strains), clindamycin (40.9 –
resistant strains), gentamicin (36.36% resistant strains) and vancomycin (31.8% -resistant strains) showed 
moderate to high resistance (Fig. 2). 
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Fig 2: The proportion of sensitive and resistant CoNS strains to the tested antibiotics 
AUG- Augmentin, AMX- Amoxicillin, ERY- Erythromycin, TET- Tetracyline, CXC- Cloxacillin, GEN- 
Gentamycin, COT- Cotrimoxazole, CHL- Chloramphenicol, OX- Oxacillin, NV- Novobiocin, DA- Clindamycin, 
VA- Vancomycin, and P- Penicillin.  
 
4. Discussion 
S. aureus, widely considered a major factor of nosocomial infections (Archer, 1998), increasingly resistant to 
methicillin (Enright et al., 2002) and other classes of antimicrobial agents is also responsible for outbreaks of 
community-acquired infections (Marcinak and Frank, 2003). CoNS, historically considered harmless with 
relatively low virulence (Kloos and Banerman, 1994; von Eiff et al., 2001), are increasingly recognized as agents 
of clinically significant infection of the bloodstream and other sites, and they often serve as reservoirs of 
antimicrobial resistance determinants. In this study, an overall prevalence of 43.6% of S. aureus compared to 
56.4% of CoNS was obtained from apparently healthy University students. This is in line with the study by 
Finney et al., (2013) who reported prevalence of 50% for S. aureus and 50% for CoNS among normal healthy 
student and staff volunteers from Ajman in the United Arab Emirates. The study by Kejela and Bacha (2013) 
also showed the overall frequency of isolation of S. aureus of 47.74% and that of CoNS of 52.26% from healthy 
primary school children and prisoners in Ethiopia. However, the observed prevalence of S. aureus in this study is 
higher than previously reported in a student community in the United States where 29% of the volunteers carried 
S. aureus (Bischoff et al., 2004). Differences in ethnicity and socio-economic status of individuals demonstrated 
through differences in living conditions, including access to and use of washing and sanitation facilities and 
differing health seeking behaviour may account for the regional differences in prevalence of S. aureus (Tong et 
al., 2012). 
It is very alarming that almost all the S. aureus strains (94-100%) isolated from the apparently healthy 
students in this study were highly resistant to methicillin (oxacillin/ cloxacillin). The results also show that the S. 
aureus isolates have high resistance to amoxicillin (94.1%) and penicillin (82.4%), which support earlier 
findings, that MRSA strains are equally resistant to all β-lactam antibiotics (Onanuga et al., 2005) which may be 
due to mecA, which is carried by a unique mobile genetic element, staphylococcal cassette chromosome mec 
(SCCmec) integrated into the S. aureus chromosome (Hiramatsu et al., 2002). The MRSA prevalence in this 
study represents more than double the rate previously reported in apparently healthy University students in Edo 
State of Nigeria (Eke et al., 2012), but comparable to the findings of Onanuga et al. (2005) which demonstrated 
that 71.7% of S. aureus isolated from the community were methicillin resistant. Other risk factors associated 
with MRSA colonization in the participants that cannot be ruled out in this study include living conditions in the 
University hostels, repeated exposure to antibiotics (at least a year prior to participation in the study), skin-to-
skin contact, sharing of University athletic equipment or sharing of personal items such as bar soap and towels 
(Weber, 2005). 
Moreover, the characterization of the MRSA isolates in this study also revealed that they have 
developed resistance to several non-β-lactam antibiotics tested; greater than 75% resistance to clindamycin 
(lincosamides), co-trimoxazole (folate pathway inhibitors), and vancomycin (glycopeptides). This finding is 
consistent with the multi-drug resistant profiles of MRSA isolates reported by Olayinka et al. (2005) who 
observed 57.7% vancomycin resistant S. aureus, Onanuga et al., (2005) who showed a high resistance to 
clindamycin (92%) and vancomycin (89%), Kumurya (2015) who showed 87.12 % methicillin resistant isolates 
with in vitro inducible clindamycin resistance, and the study by Shittu et al., (2012) in which 82.3% of S. aureus 
were resistant to co-trimoxazole. However, our results are contrary to the findings of Patel et al., 2006, Wylie 
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and Nowicki (2005), Mandelia and Shenoy (2010) who reported 80-100% MRSA susceptibility to vancomycin, 
clindamycin and co-trimoxazole.  
The CoNS isolates are one of the most important agents of nosocomial bacteremia, worldwide, which is 
complicated by the high level of methicillin resistance frequently observed among them (Diekema et al., 2001, 
NNIS System, 2004). In this study, the incidence of methicillin-resistance among CoNS isolates from the 
apparently healthy University students was 77.3%. The MRCoNS also demonstrated moderate resistance to non-
β-lactam antibiotics; co-trimoxazole (63.6%), clindamycin (40.9%), gentamycin (36.36%) and vancomycin 
(31.8%). These findings are consistent with the studies by Cuevas et al., (2004) who observed MRCoNS 
prevalence of 61.3% and resistance to gentamicin (27.8%) in Spain, and Ma et al., (2011) who reported 
MRCoNS prevalence of 79.1% and multiple resistance to clindamycin (53.7%), co-trimoxazole (58.5%) and 
gentamicin (28%) in China. The existence of MRCoNS strains susceptible to chloramphenicol (80% -sensitive 
strains) provides an opportunity for the recommendation to use this drug for empirical treatment of MRCoNS 
infections in this study population (Daniyan and Sani, 2011, Shanmuganathan et al., 2005). 
Nigeria is a country with high population density, where the indiscriminate use of common antibiotics 
in humans without prescriptions is extremely high coupled with significant abuse arising from self-medication 
which is often associated with inadequate dosage and failure to comply with treatment (Yah et al., 2008), and 
there is no regulation of the use of antibiotics in livestock and poultry (Olatoye, 2011). This combination of 
factors makes a perfect scenario for the spread of drug-resistant bacteria in the community (Yah et al., 2008; 
Olatoye, 2011). The high level resistance could be associated with earlier exposure of these drugs to isolates 
which may have enhanced development of resistance. However, since none of the participants in this study had 
received vancomycin because the drug is not available for clinical use in Nigeria (Yah et al., 2008), it is difficult 
to understand the drug selection pressure and the mechanism responsible for decreased susceptibility to 
vancomycin in these isolates. There is a possibility, however, that some of the isolates may be carrying the vanA 
operon from transposon Tn1546, acquired from vancomycin-resistant Enterococcus faecalis, which is known to 
alter cell wall structure and metabolism, but the resistance mechanisms are less well defined (Pe´richon and 
Courvalin, 2009).  
The high level of multiple drug resistance shown by the MRSA and MRCoNS isolates from apparently 
healthy student volunteers in this study is of serious concern. There is an urgent need to adopt basic principles of 
asepsis and high personal hygiene, for most staphylococcal infections are readily transmitted among susceptible 
populations by the individuals who have acquired them. We also know that the misuse of antibiotics in both 
hospital and community settings can cause MRSA and MRCoNS to become more virulent and more difficult to 
contain and treat. If antibiotics are prescribed to treat infections unnecessarily or when individuals do not 
complete their prescriptions, infections can develop a resistance to antibiotics.   
Our work has some limitations that should be mentioned. First, study participants were selected on the 
basis of a questionnaire including items on contact with the Covenant University Healthcare centre or any local 
hospital staff, or usage of antibiotics during the prior six months or presence of any skin abrasion or open wound 
prior to and during the sampling period. We cannot exclude the possibility that some study participants had 
experienced earlier hospitalization (in the prior year), the impact of living conditions in the University hostels, 
skin-to-skin contact, sharing of University athletic equipment or sharing of personal items such as bar soap and 
towels (Weber, 2005). Reliable retrospective data on antibiotic use during the months before inclusion were 
unavailable. The study involved only a small number of isolates, and the molecular characterization of MRSA 
and MR-CoNS isolates has yet to be conducted. It is well established that bacteria exhibiting a biofilm 
phenotype are recalcitrant to antimicrobial therapy (Otto, 2008; Fredheim et al., 2009; Oliveira and Cerca, 2013). 
Studies are underway to determine the biofilm formation ability of CoNS stains isolated in this study and to 
assess whether their antimicrobial resistance can be intimately related to their biofilm formation ability.  
 
5. Conclusion 
This study has demonstrated high prevalence of MRSA and MRCoNS from apparently healthy student 
volunteers in Ota, Nigeria. It has also demonstrated significant resistance of these strains, especially against non-
β-lactam antibiotics such as clindamycin and co-trimoxazole (both commonly used), and vancomycin that is 
used in severe cases of MRSA and MRCoNS infections in the Western world, but not yet available and 
prescribed in Nigeria. This study underlines the need for periodic surveillance studies of this type, reassessment 
of policies on antibiotics use within and outside the University environments, development and enforcement of 
measures to prevent the spread of MRSA and MRCoNS infections in the community including proper care of 
wounds, frequent washing of hands and avoidance of sharing personal items.  
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